Eliasson M, Jansson J H, Nilsson P, Asplund K
Department of Medicine, Luleå Hospital, Sweden.
J Hypertens. 1997 Apr;15(4):349-56. doi: 10.1097/00004872-199715040-00005.
To investigate components of the haemostatic and fibrinolytic system in borderline hypertensives and hypertensives, drug-treated or not, from a defined population.
A randomly selected sample of the population of northern Sweden, 1558 subjects aged 25-64 years, was studied. Eight per cent of them were being treated with antihypertensive drugs (trHT). Remaining subjects were classified according to their mean diastolic blood pressure (DBP). Normotension, DBP < 85 mmHg, was found in 63%, borderline hypertension (bHT), DBP 85-94 mmHg, in 21% and untreated hypertension (uHT), DBP > or = 95 mmHg, in 8% of the subjects.
Mean age increased from the normotensive group through the bHT and uHT groups to the trHT group, members of which were the oldest. Age-adjusted values for the body mass index, waist: hip ratio, serum triglyceride and Phadeseph plasma insulin levels increased with each level of hypertension. Plasma fibrinogen levels and plasminogen activator inhibitor type 1 activity (in men) increased stepwise from normotensives through bHT and uHT to the highest values found in the trHT group. The tissue plasminogen activator (tPA) activity in men declined strongly across the groups, trHT having the lowest fibrinolytic activity (P < 0.001). tPA antigen levels increased strongly from normotensives through bHT to uHT, but then were lower in the trHT group. Even after adjustment for possible confounders, men in the uHT group had 21% higher (P = 0.027) tPA antigen levels than did the normotensives. In bHT men, the tPA antigen and plasminogen activator inhibitor type 1 activities were 14 and 24% respectively, higher (P < 0.01) than those in the normotensives.
Hypertension is associated with multiple metabolic and fibrinolytic disturbances that are accentuated in drug-treated hypertensives and already discernible in subjects with borderline hypertension. Decreased fibrinolysis is associated with, and possibly secondary to, metabolic disturbances linked to the insulin-resistance syndrome. The independent increase in tPA antigen in hypertensive men might indicate an endothelial dysfunction.
研究特定人群中临界高血压患者和高血压患者(无论是否接受药物治疗)的止血和纤溶系统成分。
对瑞典北部人群中随机抽取的1558名年龄在25 - 64岁的受试者进行研究。其中8%的受试者正在接受抗高血压药物治疗(trHT)。其余受试者根据其平均舒张压(DBP)进行分类。63%的受试者血压正常,DBP < 85 mmHg;21%的受试者为临界高血压(bHT),DBP 85 - 94 mmHg;8%的受试者为未治疗的高血压(uHT),DBP≥95 mmHg。
平均年龄从血压正常组经临界高血压组和未治疗高血压组到接受治疗的高血压组逐渐增加,接受治疗的高血压组受试者年龄最大。体重指数、腰臀比、血清甘油三酯和Phadeseph血浆胰岛素水平的年龄校正值随高血压程度的增加而升高。血浆纤维蛋白原水平和纤溶酶原激活物抑制剂1型活性(男性)从血压正常者经临界高血压患者和未治疗高血压患者到接受治疗的高血压组逐步升高,在接受治疗的高血压组中达到最高值。男性组织纤溶酶原激活物(tPA)活性在各组中显著下降,接受治疗的高血压组纤溶活性最低(P < 0.001)。tPA抗原水平从血压正常者经临界高血压患者到未治疗高血压患者显著升高,但在接受治疗的高血压组中较低。即使对可能的混杂因素进行校正后,未治疗高血压组男性的tPA抗原水平仍比血压正常者高21%(P = 0.027)。在临界高血压男性中,tPA抗原和纤溶酶原激活物抑制剂1型活性分别比血压正常者高14%和24%(P < 0.01)。
高血压与多种代谢和纤溶紊乱相关,这些紊乱在接受药物治疗的高血压患者中更为突出,在临界高血压患者中已可察觉。纤溶降低与胰岛素抵抗综合征相关的代谢紊乱有关,且可能是其继发结果。高血压男性中tPA抗原的独立升高可能表明存在内皮功能障碍。